Ligand Pharma (LGND) Tops Q3 EPS by 6c, Offers FY20 and FY21 Guidance
Go back to Ligand Pharma (LGND) Tops Q3 EPS by 6c, Offers FY20 and FY21 Guidance| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 243.28 +5.53 (2.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $237.75 | 52 Week High | $139.79 | |||
| Open | $241.98 | 52 Week Low | $82.07 | |||
| Day High | $245.00 | P/E | 565.77 | |||
| Day Low | $237.00 | EPS | $0.43 | |||
| Volume | 173,529 | |||||

